News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zeltia Group (18494051.MA)'s PharmaMar S.A. in Deal With US Medimetriks Pharmaceuticals, Inc.



6/10/2009 7:20:23 AM

Bookmark and Share

Reuters -- Spanish biotechnology company Zeltia (ZEL.MC) said on Wednesday that its PharmaMar unit has reached a deal with the U.S. company Medimetriks to develop its Kahalalide F drug in the treatment of psoriasis.


Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES